Development of an indirect enzyme-linked immunosorbent assay for detecting equine serum antibodies to the lipopolysaccharide of Salmonella abortusequi.

The research team developed a new method for detecting antibodies in horse serum against a bacteria-related substance in an effort to improve testing for equine paratyphoid. The method, known as an indirect enzyme-linked immunosorbent assay (IELISA), was found to be more reliable than an existing test.

Development of the Indirect Enzyme-Linked Immunosorbent Assay

• The article documented the development of the IELISA, a strategy for detecting equine serum antibodies.
• The object of detection is lipopolysaccharide, an endotoxin closely associated with a specific strain of the bacterium Salmonella known as Salmonella enterica subsp. enterica serovar Abortusequi, which causes equine paratyphoid.
• The developed IELISA has shown promise as a diagnostic tool and provided an enhancement over the existing tube agglutination test (TAT).

Comparison with the Tube Agglutination Test

• Following the IELISA development, a comparison was made with an existing test known as the tube agglutination test (TAT).
• The TAT measures the agglutination, or clumping, of pathogens in the presence of antibodies, thus indicating an immune response.
• However, the IELISA proved more effective in detecting antibodies against Salmonella Abortusequi’s lipopolysaccharide endotoxin.

Potential of the IELISA

• The research team suggested that the developed IELISA could consequently be a more appropriate method for detecting serum antibodies to Salmonella Abortusequi.
• The results encourage further exploration into the use of IELISA as a diagnostic tool for equine paratyphoid.